Dynavax Technologies Corp
DVAXDelisted Feb 10, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029142
Dynavax Technologies Corp was delisted on Feb 10, 2026; its insiders filed their last Form 4 on Feb 11, 2026; 267 institutions reported holding it in 13F filings for Q4 2025, worth $1.73B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Dynavax Technologies Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Dynavax Technologies Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kroin David | 10% Owner | 0 | Feb 11, 2026 | 1 |
| Deep Track Capital, LP | 10% Owner | 0 | Feb 11, 2026 | 1 |
| Deep Track Biotechnology Master Fund, Ltd. | 10% Owner | 0 | Feb 11, 2026 | 1 |
| Kisner Daniel L | Director | 0 | Feb 10, 2026 | 1 |
| Silvernail Lauren P | Director | 0 | Feb 10, 2026 | 1 |
| Cano Francis | Director | 0 | Feb 10, 2026 | 1 |
| Myers Scott Dunseth | Director | 0 | Feb 10, 2026 | 1 |
| Slebir John L | SVP General Counsel | 0 | Feb 10, 2026 | 2 |
| Novack David F | President & COO | 0 | Feb 10, 2026 | 3 |
| Spencer Ryan | CEO and Director | 0 | Feb 10, 2026 | 2 |
| MacDonald Kelly | SVP and CFO | 0 | Feb 10, 2026 | 2 |
| Sun Elaine D | Director | 0 | Feb 10, 2026 | 1 |
| MacGregor Brent | Director | 0 | Feb 10, 2026 | 1 |
| Emini Emilio | Director | 0 | Feb 10, 2026 | 1 |
| Metzinger Joseph Anthony | VP, Chief Accounting Officer | 0 | Feb 10, 2026 | 2 |
| Paradiso Peter R. | Director | 24,829 | Jun 13, 2025 | 0 |
| Janssen Robert | SVP and CMO | 77,485 | Feb 20, 2025 | 0 |
| Burgess Justin | VP Finance & CAO | 4,170 | Feb 12, 2025 | 0 |
| Phillips Peggy V | Director | 43,804 | May 28, 2024 | 0 |
| Eastland Julia Marie | Director | 16,071 | May 28, 2024 | 0 |
| Hack Andrew A. F. | Director | 915,000Indirect | Aug 10, 2023 | 0 |
| Ricciardi Natale S | Director | – | May 27, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 (view filing) | May 31 | 3 days | Cano FrancisDirector | SSale | −3.62K | $11.93 | −$43.1K | −8.9%36.9K after | |
| Mar 10, 2025 (view filing) | Mar 7 | 3 days | Novack David FPresident & COO | SSale | −32.8K | $14.39 | −$471.5K | −59.7%22.1K after | 10b5-1 |
| Mar 20, 2025 (view filing) | Mar 18 | 2 days | Novack David FPresident & COO | SSale | −14.0K | $13.58 | −$190.4K | −63.4%8.08K after | 10b5-1 |
| Mar 26, 2025 (view filing) | Mar 24 | 2 days | Novack David FPresident & COO | SSale | −10.0K | $14.00 | −$140.0K | −55.3%8.08K after | 10b5-1 |
| Aug 22, 2025 (view filing)8:49 PM ET | Aug 21-22 | 1 day | Kroin David and 2 others10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.07M | $10.82 | −$22.4M | −11.6%15.7M after | 2 lots |
| Aug 25, 2025 (view filing) | Aug 22 | 3 days | Myers Scott DunsethDirector | PPurchase | +3.80K | $10.82 | +$41.1K | +12.2%35.0K after | |
| Dec 29, 2025 (view filing) | Dec 24 | 5 days | Novack David FPresident & COO | SSale | −30.0K | $15.49 | −$464.7K | −21.2%111.5K after | |
| Jan 20, 2026 (view filing) | Jan 15 | 5 days | Novack David FPresident & COO | SSale | −114.0K | $15.64 | −$1.78M | −64.3%63.3K after |